(Q79446056)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17183611%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17183611%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17183611%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Carl E Ruby

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17183611%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Daniel Haley

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17183611%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Andrew D Weinberg

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17183611%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17183611%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

23 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17183611%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17183611%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

157-166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17183611%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17183611%20AND%20SRC:MED&resulttype=core&format=json

Maintenance and attrition of T-cell memory

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Immunological memory and protective immunity: understanding their relation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Adaptive immunity and enhanced CD8+ T cell response to Listeria monocytogenes in the absence of perforin and IFN-gamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Response of naïve and memory CD8+ T cells to antigen stimulation in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Functional differences between memory and naive CD8 T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

CD8+ T cell contraction is controlled by early inflammation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Signaling through OX40 (CD134) breaks peripheral T-cell tolerance.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

The OX-40 receptor provides a potent co-stimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

4-1BB and OX40 dual costimulation synergistically stimulate primary specific CD8 T cells for robust effector function.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

The CD8+ T cell repertoire against Her-2/neu antigens in neu transgenic mice is of low avidity with antitumor activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Costimulation of CD8 T cell responses by OX40.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Lineage relationship and protective immunity of memory CD8 T cell subsets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

OX40 ligation enhances primary and memory cytotoxic T lymphocyte responses in an immunotherapy for hepatic colon metastases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

CD4+CD25+ regulatory T cells attenuate the phosphatidylinositol 3-kinase/Akt pathway in antigen-primed immature CD8+ CTLs during functional maturation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

The costimulation-regulated duration of PKB activation controls T cell longevity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

OX40 and Bcl-xL promote the persistence of CD8 T cells to recall tumor-associated antigen.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Engagement of the OX-40 receptor in vivo enhances antitumor immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636428

7 January 2021

Identifiers

DOI

10.1002/EJI.200636428

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17183611%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference